TACOTINIB ER 11 is a specialized formulation containing Tofacitinib Extended Release 11 mg. Designed to offer a sustained and controlled release of medication, it aims to provide long-lasting relief for patients suffering from autoimmune diseases like rheumatoid arthritis. Tofacitinib is a Janus kinase (JAK) inhibitor that modulates the immune system to reduce inflammation and pain associated with autoimmune disorders. This extended-release formulation ensures a steady supply of the medication in the bloodstream, enhancing its therapeutic effects and minimizing the frequency of dosing.

Key Benefits:

• Long-Lasting Relief: The extended-release formulation ensures a consistent release of Tofacitinib, offering prolonged symptom relief with fewer doses.
• Reduced Inflammation: Tofacitinib effectively reduces inflammation and pain, improving the quality of life for patients with rheumatoid arthritis and other autoimmune conditions.
• Enhanced Mobility: By alleviating joint pain and stiffness, TACOTINIB ER 11 helps improve physical function and mobility.
• Convenient Dosing: The extended-release nature of the medication reduces the need for frequent dosing, promoting better adherence to the treatment regimen.

How Does It Work?

Tofacitinib, the active ingredient in TACOTINIB ER 11, works by inhibiting Janus kinase (JAK) enzymes. These enzymes play a crucial role in the signaling pathways that regulate immune responses and inflammation. By blocking these enzymes, Tofacitinib disrupts the inflammatory process, thereby reducing the production of pro-inflammatory cytokines. This action helps in managing the symptoms of autoimmune diseases, such as pain, swelling, and joint damage, providing effective relief and improving patient outcomes.

Directions for Use:

1. Dosage: Take one tablet of TACOTINIB ER 11 as prescribed by your healthcare provider. The typical dosage is once daily, preferably at the same time each day.
2. Administration: Swallow the tablet whole with a glass of water. Do not crush, chew, or break the tablet, as this may affect the extended-release properties of the medication.
3. Food: TACOTINIB ER 11 can be taken with or without food. However, taking it with food may help reduce any potential stomach upset.
4. Consistency: For optimal results, take the medication regularly and adhere to the prescribed dosage schedule.

Side Effects:

Like all medications, TACOTINIB ER 11 may cause side effects, although not everyone will experience them. Common side effects include:

• Gastrointestinal Issues: Nausea, diarrhea, or stomach pain.
• Infections: Increased susceptibility to infections due to immune system modulation.
• Headache: Mild to moderate headaches may occur.
• Elevated Liver Enzymes: Regular monitoring of liver function is recommended.
• Blood Disorders: Changes in blood cell counts, such as decreased white blood cells or red blood cells.
• Allergic Reactions: Rash, itching, or swelling, particularly of the face, tongue, or throat.

If You Need More Information About TACOTINIB ER 11 Click here